… diagnosis is important, given the emergence of effective therapies which have revolutionised
the management of transthyretin amyloidosis. … of diagnostic techniques and management …

… Most common CA types are light chain amyloidosis (AL) caused by monoclonal immunoglobulin
light chains and transthyretin amyloidosis (ATTR) caused by either mutated or wild-type …

… This reaffirms the need for a logical diagnostic algorithm to definitively diagnose and commence
… Refinement of our diagnostic and management techniques will likely help control this …

Transthyretin amyloidosis (ATTR amyloidosis) is a disease caused by deposition of transthyretin
fibrils in organs and tissues, which causes their dysfunction. The clinical heterogeneity …

… The first siRNA-based drug in history to be recently approved by the US FDA for the
treatment of hereditary transthyretin amyloidosis was patisiran, which directly binds to mRNA, …

… diagnosis of CA, including the interpretation of indeterminate cardiac imaging findings, the
best technique to screen asymptomatic transthyretin amyloidosis … for transthyretin amyloidosis‐…

… Thus, it is crucial for clinicians to be aware of this clinical entity for early diagnosis and proper
treatment. In this mini‐review, we focus on recent advances in diagnosis and treatment of …

… developments in amyloidosis diagnosis and management and to provide a diagnostic and
treatment framework to improve the management of patients with all forms of amyloidosis. …

Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy (formerly known as
Familial Amyloid Polyneuropathy) is a rare disease due to mutations in the gene encoding …

… imaging is diagnostic of transthyretin amyloidosis with … diagnosing ATTR CA, and
representative scans show diffuse myocardial uptake in a patient with cardiac transthyretin …